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c TÜBİTAK
⃝
doi:10.3906/kim-1707-9

Research Article

Multiwall carbon nanotube paste electrode as a sensor for sensitive determination
of deferasirox in the presence of uric acid: application for the analysis of
pharmaceutical and biological samples

1

Golnaz PARVIZI FARD1 , Reza EMAMALI SABZI1,2,∗
Department of Analytical Chemistry, Faculty of Chemistry, Urmia University, Urmia, Iran
2
Institute of Biotechnology, Urmia University, Urmia, Iran

Received: 03.07.2017

•

Accepted/Published Online: 19.12.2017

•

Final Version: 27.04.2018

Abstract: In this work, the electrochemical oxidation of deferasirox at a multiwall carbon nanotube paste electrode
(MWCNTPE) was described. The electrochemical behavior of deferasirox was studied using cyclic voltammetry and
chronoamperometry techniques and parameters such as charge transfer coeﬃcient ( α) , the number of electrons involved
in the rate-determining step ( na ) , and diﬀusion coeﬃcient ( D) were calculated. The capability of the electrode for the
determination of deferasirox at low concentrations was investigated using the diﬀerential pulse voltammetry technique.
It was found that the calibration graph of deferasirox was linear in the concentration range of 0.16–16.5 µ M and its
detection limit was determined to be approximately 0.1 µ M. The diﬀusion coeﬃcient was calculated to be 1.8 × 10 −6
cm 2 s −1 for deferasirox. The diﬀerential pulse voltammetry method could be used as an eﬀective technique for the
determination of deferasirox at the MWCNTPE in the presence of uric acid. The MWCNTPE was successfully used as
a sensor for sensitive detection of deferasirox in pharmaceutical and biological samples.
Key words: Multiwall carbon nanotube paste electrode, deferasirox, cyclic voltammetry, chronoamperometry, diﬀerential pulse voltammetry, electrochemical detection

1. Introduction
Deferasirox [4-[(3 Z ,5 E)-3,5-bis(6–oxo–1–cyclohexa-2,4-dienylidene)-1,2,4–triazolidin-1-yl]benzoic acid is an oral
iron chelator and is a tridentate ligand with high aﬃnity for binding to iron(III) with a metal-to-ligand ratio of
2:1. 1 Deferasirox is a novel synthetic drug and its main application is reducing chronic iron overload in patients
undergoing numerous blood transfusions due to conditions such as beta-thalassemia, sickle cell disease, and
other chronic anemias. 1,2
Iron overload can damage the liver, myocardium, spleen, and endocrine system over time. 3,4 Therefore,
maintaining safe iron concentrations in tissues is very important, and this can be achieved via chelation
treatment. 5 However, like many other drugs, overdose of deferasirox can occur, which could be extremely
dangerous. In the case of overdose, patients suﬀer from severe side eﬀects such as loss of appetite, yellow eyes
or skin, vomiting, diarrhea, and unusual bleeding or bruising.
Drug analysis of pharmaceutical and biological samples has significant eﬀects on public health. To our
knowledge, limited research has been reported on the analysis of deferasirox. Some analytical methods such
as liquid chromatography, spectroscopy, and spectrofluorometry have been reported for the determination of
∗ Correspondence:
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deferasirox. 1,2,6−12 However, these methods are time-consuming or solvent usage-intensive. Compared with
other methods, electrochemical techniques, which oﬀer faster, cheaper, and safer analysis methods, have drawn
much attention and have been used for the determination of a wide range of pharmaceuticals. 13−16 A limited
number of electrochemical methods have been reported for determining deferasirox. 17−19
Carbon paste electrodes (CPEs) have several advantages over other carbonaceous or noble metal electrodes such as low background current, feasibility of incorporating diﬀerent modifiers during paste preparation,
easy preparation methods, simple surface renewal, low cost, and potential of miniaturization. 19 To date, diﬀerent types of carbonaceous materials such as graphite, acetylene black, carbon nanofibers, carbon microspheres,
and carbon nanotubes have been used in the preparation of CPEs. 21−24
Nanotechnology has become one of the most interesting fields in science and technology. 25 Carbon
nanotubes are important nanostructures due to their unique properties including tensile strength one hundred
times that of steel, high thermal conductivity, high mechanical strength, electrical conductivity similar to copper,
and capability of carrying much higher currents. 25−29
In this paper, we have focused on the electrochemical oxidation of deferasirox at a multiwall carbon
nanotube paste electrode (MWCNTPE) using cyclic voltammetry (CV) and chronoamperometry techniques.
We have also discussed the capability of this electrode for sensitive determination of deferasirox using diﬀerential pulse voltammetry. Finally, we have used the MWCNTPE as a sensor for determining deferasirox in
pharmaceutical and biological samples.
2. Results and discussion
2.1. Surface morphology of the MWCNTPE and CPE
Scanning electron microscopy was employed to characterize the surfaces of both the MWCNTPE and CPE as
shown in Figure 1. For CPE (Figure 1A), a dense, scaly, and porous surface appeared with separated carbon
layers due to the heterogeneous dispersion of carbon powder, whereas for the MWCNTPE (Figure 1B), carbon
nanotubes were visible at the edges of the separated carbon sheets.
2.2. Characterization of the MWCNTPE and CPE by electrochemical impedance spectroscopy
Figure 2 shows Bode (Figure 2A) and Nyquist (Figures 2B and 2C) plots for the CPE and MWCNTPE,
respectively. An equivalent electrical circuit model, shown in the inset of Figure 2A, was proposed to fit the
results obtained by electrochemical impedance spectroscopy (EIS) analysis. In this model, R 1 is electrolyte
resistance, CPE 1 is the double-layer constant phase element, R 2 is charge transfer resistance, and W 1 is
Warburg resistance, which is related to mass transfer resistance. The fitted EIS parameters are presented in
Table 1.
Table 1. The fitting EIS parameters for the CPE and MWCNTPE.

Sample
R1 (Ω cm2 ) CPE1 – P
CPE
47.54
0.94
MWCNTPE 79.86
0.77

CPE1 – T (Ω−1 cm−2 sn ) R2 (Ω cm2 )
4.96 × 10−7
26,822
4.52 × 10−5
22,459

WR
6.88 × 105
2.15 × 105

Chi-square
0.002235
0.010223

The charge transfer resistances (R 2) of the CPE and MWCNTPE were 26,822 and 22,459 Ω cm 2 ,
respectively. Figure 2A clearly shows that the charge transfer resistance of the MWCNTPE was decreased.
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Figure 1. SEM images of a) CPE and b) MWCNTPE.

2.3. Preliminary investigation using cyclic voltammetry
A preliminary investigation using CV was conducted to evaluate the electrochemical behavior of deferasirox at
the CPE. Figure 3 shows cyclic voltammograms of the CPE (curves a and b) and the MWCNTPE (curves c
and d) in 0.1 M phosphate buﬀer solution containing 0.25 M KCl at pH 7 (as the supporting electrolyte) in the
absence (a, c) and presence (b, d) of 0.4 mM deferasirox at the scan rate of 50 mV s −1 .
Curve a of Figure 3 is related to the CPE in the absence of deferasirox. Upon the addition of 0.4 mM
deferasirox to the supporting electrolyte solution, a weak anodic peak with the potential of 0.82 V appeared at
the CPE (Figure 3, curve b), with peak current of 50 µ A. Curve c of Figure 3 is related to the MWCNTPE in the
supporting electrolyte solution in the absence of deferasirox. Similarly, in the presence of 0.4 mM deferasirox,
a sharp anodic peak with the potential of 0.65 V and peak current of 175 µA was observed at the MWCNTPE
(Figure 3, curve d).
The analyzed results indicated that the MWCNTPE had excellent catalytic activity for the oxidation of
deferasirox as it presented a much higher peak current at a lower peak potential (0.65 mV) compared to that
obtained for the CPE.
2.4. Eﬀect of pH
At pH levels below 5, the deferasirox solution became turbid, probably because of the low solubility of deferasirox
at these pH values. At pH levels above 10, the currents of oxidation peaks of deferasirox were decreased and peak
shapes were deformed. For this reason, the eﬀect of the pH of the supporting electrolyte on the electrooxidation
of deferasirox at the MWCNTPE was investigated by diﬀerential pulse voltammetry using 16 µ M deferasirox in
0.1 M phosphate and 0.25 M KCl solutions at pH values of a) 5, b) 6, c) 7, d) 8, e) 9, and f) 10 (Figure 4A). The
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Figure 2. A) Bode plots for CPE (a) and MWCNTPE (b), and B) Nyquist plot for CPE. C) Nyquist plot for MWCNTPE
in a mixture solution of 5 mM [Fe(CN) 6 ] 3−/4− and 2 M KCl. Inset: Equivalent electrical circuit model.
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Figure 3. Cyclic voltammograms of CPE in the (a) absence and (b) presence of 0.4 Mm deferasirox and MWCNTPE
in the (c) absence and (d) presence of 0.4 mM deferasirox at the scan rate of 50 mV s −1 . Supporting electrolyte: 0.1 M
phosphate buﬀer solution and 0.25 M KCl (pH 7).

maximum peak current for deferasirox oxidation was obtained at pH 7 (Figure 4B). Thus, pH 7 was selected
as the optimum pH for further electrochemical studies of deferasirox. Figure 4A shows that by decreasing the
pH of the supporting electrolyte, the oxidation peak of deferasirox was shifted towards more positive potentials.
The variation of peak potential (Ep ) as a function of pH gave a straight line with a negative slope of 66 mV/pH
(Figure 4C), which was closely related to the anticipated Nernstian value of 59 mV/pH at 25 ◦ C for reactions
with an equal number of protons and electrons.
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Figure 4. A) Diﬀerential pulse voltammograms of 16 µ M deferasirox at MWCNTPE at various pH levels of (a) 5, (b)
6, (c) 7, (d) 8, (e) 9, and (f) 10. B) Plot of variations of peak currents versus pH. C) Plot of variations of peak potentials
versus pH. Supporting electrolyte: 0.1 M PBS and 0.25 M KCl.

2.5. Eﬀect of scan rate
Cyclic voltammetry with diﬀerent potential sweep rates was used to determine the eﬀect of scan rate on the
deferasirox oxidation peak. Figure 5A shows voltammograms of 0.2 mM deferasirox in the supporting electrolyte
at scan rates ranging from 10 to 500 mV s −1 .
At scan rates above 500 mV s −1 the peak of deferasirox was deformed and was not sharp enough for the
determination of EP . Since accurate evaluation of EP was necessary for analytical applications, the eﬀect of
scan rate on the electrooxidation of deferasirox was investigated in the range of 10–500 mV s −1 . The oxidation
peak current of deferasirox was linearly increased with the square root of the scan rate (Figure 5B), suggesting
that the reaction was controlled by mass transfer. The peak potential for the oxidation of deferasirox was
also shifted to more positive potentials by increasing the scan rate (Figure 5C), suggesting a kinetic limitation
in the electrode reaction. In other words, by increasing the potential scan rate, the oxidation of deferasirox
was accomplished at more positive potentials as a result of kinetic limitation involved in the electron-transfer
reaction. The slope of variation of EP versus log v can be used for the calculation of some kinetic parameters
such as α (charge transfer coeﬃcient) and na (the number of electrons involved in the rate-determining step).
To obtain information on charge transfer coeﬃcient (α) , the number of electrons involved in the ratedetermining step (na ) , and the Tafel slope (b), we used Eq. (1) for electric potential (Ep ) , which is valid for a
totally irreversible diﬀusion-controlled process:
EP = b/2 log ν > +a.

(1)

Here, b is the Tafel slope, ν is the potential scan rate, and a is the intercept including the standard rate
constant under experimental conditions. 30
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Figure 5. A) Cyclic voltammograms of MWCNTPE in 0.1 M PBS and 0.25 M KCl (pH 7) containing 0.2 mM deferasirox
at scan rates of 10, 25, 50, 75, 100, 150, 200, 250, 300, 350, 400, and 500 mV s−1 . B) Plot of variations of peak currents
( Ip ) versus ν 1/2 . C) Plot of variations of peak potentials ( Ep ) versus log ν . D) Tafel plot obtained from currentpotential
curves recorded at the MWCNTPE in the presence of 0.2 mM deferasirox at the scan rate of 20 mV s−1 at pH 7.

Based on Eq. (1), the slope of EP as a function of log ν (Figure 5C) was found to be 64 mV/decade;
thus, the Tafel slope was b = 2 × 64 = 128 mV, which gave 0.46 for (1 – α) na . We also determined the value
of (1 – α)

na using another method. A Tafel plot was constructed using background-corrected data from the

rising part of the current–voltage curve at the scan rate of 20 mV s −1 (Figure 5D). For 0.2 mM deferasirox, a
slope of 8.5 (V/decade) −1 was witnessed, which gave a value of approximately 0.46 for (1 – α)

na .

By assuming α = 0.5, the value of na from two diﬀerent methods was obtained to be 1.
2.6. Calculation of diﬀusion coeﬃcient (D)
Chronoamperometry, as an eﬀective electroanalytical method, was used for the evaluation of the diﬀusion
coeﬃcient of deferasirox. For this purpose, the Cottrell equation was used: 18,31,32
πτ i =

nf AcD1/2
1/21/2

.

(2)

Figure 6 shows the current–time profiles obtained from setting the potential of the MWCNTPE working
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electrode at 0.8 V in the presence of a) 1 mM, b) 1.5 mM, and c) 3 mM deferasirox. As can be seen,
chronoamperograms of the analyte reached a steady state in approximately 3 s. Hence, we concluded that
the response time of the electrode was 3 s. At long experimental times (t > 1.5 s, or t−1/2 < 0.8 s), where the
electrocatalyzed oxidation rate of deferasirox exceeded that of deferasirox diﬀusion, the current demonstrated
a diﬀusional nature. In this region, the graph of current I versus t−1/2 gave a straight line (Figure 6 (inset
A)), the slope of which was used to calculate the diﬀusion coeﬃcient D of the analyte. From the graphs of
these slopes versus c (Figure 6 (inset B)), D was found to be 1.8 × 10 −6 cm 2 s −1 for deferasirox, which was
comparable with previous reports. 17,18
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Figure 6. Chronoamperograms of MWCNTPE in the presence of (a) 1, (b) 1.5, and (c) 3 mM deferasirox in 0.1 M PBS
and 0.25 M KCl with pH 7; potential step = 0.8 V. Inset A: Plot of variation of I versus t−1/2 , inset B: plot of slopes
(obtained from inset A) versus c.

2.7. Analytical aspects
In this section, the capability of the MWCNTPE to determine deferasirox is described. Diﬀerential pulse
voltammetry (DPV), a sensitive analytical technique, was used for the determination of deferasirox at low
concentrations under optimum conditions.
2.7.1. Diagnostic performance
To assess the diagnostic performance of the proposed system, the MWCNTPE was immersed in a supporting
electrolyte solution (pH 7) containing various concentrations of deferasirox and corresponding diﬀerential pulse
voltammograms were recorded.
Figure 7A displays diﬀerential pulse voltammograms obtained from the addition of increasing amounts
of deferasirox. The calibration graph shown in Figure 7B was linear in the range of 0.16–16.5 µ M with a
correlation coeﬃcient of 0.998. The limit of detection was 0.1 µ M, which was calculated by:
yLOD (I) = yB + 3Sy/x ,

(3)

y(I) = 0.170 + 0.3791c(µM ),

(4)

and the regression equation was:
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Figure 7. A) DPV results obtained from addition of increasing levels of deferasirox (0.16, 0.47, 1.14, 1.57, 2.34, 3.11,
4.56, 5.76, 7.61, 9.42, 11.19, 14.65, 16.3 µ M) in 0.1 M PBS and 0.25 M KCl (pH 7). B) Calibration graph.

where yB is the signal of the blank (here, the intercept of the calibration graph) and Sy/x is the standard
deviation of the blank (here, the SD of the calibration graph). 32 RSD was 1.8% for 4 successive determinations
of 10 µ M deferasirox solution, indicating remarkable reproducibility of the detection method.

2.7.2. Interference experiment
Interference experiments for detecting deferasirox in the presence of diﬀerent species were conducted by recording
voltammograms of deferasirox before and after the addition of these species and comparing their current
responses. Deferasirox can coexist with some species such as lactose, glucose, F − , uric acid, and dopamine
in biological samples.
Interference experiments for the detection of deferasirox in the presence of 5 mM of each of these species
were conducted by comparing current responses before and after the addition of the interferents to 0.1 M
phosphate buﬀer solution containing 15 µ M deferasirox.
The obtained results demonstrated that deferasirox peak currents before and after the addition of these
species did not have significant diﬀerences and thus the above mentioned species did not interfere in the
determination of deferasirox.
2.7.3. Determination of deferasirox in the presence of uric acid
Figure 8 shows diﬀerential pulse voltammograms of increasing amounts of deferasirox in the presence of an
aliquot of uric acid. The calibration curve is presented in the inset of Figure 8. As shown in this figure, the
calibration curve was linear in the concentration range of 0.83–16.9 µ M. This study confirmed the applicability
of the developed sensor for the determination of deferasirox in the presence of uric acid.

2.7.4. Determination of deferasirox in pharmaceutical and biological samples
To demonstrate the capability and potential applications of the prepared electrode for sample analysis, the
proposed method was applied for the analysis of some real samples and the obtained results are presented in
Table 2. The amounts of deferasirox in real samples were determined using the DPV technique and a standard
addition method.
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graph.
Table 2. Results for the determination of deferasirox in pharmaceutical and biological samples.

Sample
Deferasirox tablet, 125 mg
Deferasirox tablet, 250 mg
Deferasirox tablet, 500 mg
Urine
a

Detected
amounta
122.5 mg
243 mg
490 mg

Spiked
100 mg
100 mg
200 mg
1 µM

Found
amounta
220.3 mg
340 mg
687.3 mg
0.98 µM

RSD
(%)
2.1
1.5
1.2
1.6

Recovery
(%)
97.8
97
98.6
98 %

Average of three replicate determinations.

2.7.5. Comparative study of the performances of the existing methods
The electrochemical and nonelectrochemical performances of some previously published methods for the determination of deferasirox are summarized in Tables 3 and 4. As shown in these tables, the dynamic range of
the proposed methods was comparable with those of other methods. The detection limit and sensitivity of the
proposed method were also acceptable.
2.7.6. Stability of the sensor
Voltammograms of a specified concentration of deferasirox were recorded by the developed sensor about 7 and
30 days after electrode preparation. About 7 days after the preparation of electrode, the sensor retained about
98% of its initial sensitivity for the oxidation of deferasirox, while a month later, 93% of its initial eﬃciency was
retained. Therefore, the MWCNTPE can be used as a sensor due to its long-term stability.
The peak current of freshly prepared deferasirox 1 week after the preparation of the electrode had not
changed significantly and 95% of the eﬃciency was retained; however, the deferasirox solution was prepared
freshly.
2.8. Conclusions
The MWCNTPE exhibited good electroactive characteristics for the electrooxidation of deferasirox. Compared
to other options, this method had the advantages of low cost, simplicity, and high sensitivity and did not need
time-consuming sample pretreatment steps.
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Table 3. Comparison of the developed method with previously reported electrochemical techniques with diﬀerent
electrodes for the determination of deferasirox.

Electrochemical
Method

Amperometry

Amperometry
Amperometry
Diﬀerential pulse
voltammetry

Electrode
Carbon paste electrode
modified with nanoparticles
of Fe2 O3 coreNaCo[Fe(CN)6 ] shell
Nickel oxyhydroxidemodified nickel electrode
Cobalt oxide nanoflakemodified platinum electrode
Multiwall carbon nanotube
paste electrode

Linear range
(µM)

Detection limit
(µM)

Ref.

0.23–5.8

0.91

19

132–1020

28

17

99–650

6.67

18

0.15–16.5

0.1

This study

Table 4. Comparison of the developed method with previously reported nonelectrochemical techniques for the determination of deferasirox.

Method
UV–spectroscopy
RPHPLC–UV
UV–spectroscopy
Spectrofluorometry
Diﬀerential pulse voltammetry

Linear range (µM)
13.35–80.01 µM
(5 to 30 µg/mL)
2.67–16.02 µM
(1 to 6 µg/mL)
5.4–32.4 µM
(2 to 12 µg/mL)
0.005–5
0.15–16.5

Detection limit (µM)
1.07 µM
(0.40 µg/mL)
0.27 µM
(0.107 µg/mL)
0.66 µM
(0.247 µg/mL)
1.5 × 10−3
0.1

Ref.
2

2

12
10

This study

The MWCNTPE that was used as a working electrode in this study possessed the advantages of both
CPEs and nanomaterials. Preparation of this electrode was convenient and the nanotubes used in the manufacturing of the electrode caused the high sensitivity of this method. The electrochemical behavior of deferasirox
was investigated by this electrode using CV and chronoamperometry. The results demonstrated that the ratedetermining step was a one-electron process. Kinetic parameters such as D and α were also calculated. Finally,
we used the DPV method to investigate the suitability of the electrode for the determination of deferasirox.
The results indicated that the DPV method could be used as an eﬀective technique for the determination of
deferasirox for the MWCNTPE. The developed sensor was successfully used for the determination of deferasirox
in urine and deferasirox tablet samples.
3. Experimental
3.1. Chemicals and reagents
Deferasirox, uric acid, and graphite powder were purchased from Merck. Multiwall carbon nanotubes (MWCNTs) of various concentric tube wall numbers (3–15) and lengths (1–10 µ m) were purchased from Aldrich.
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Supporting electrolyte solutions were prepared using 0.1 M phosphate (which was prepared by mixing stock
solutions of K 2 HPO 4 and KH 2 PO 4 solution) and 0.25 M KCl and the pH was adjusted using saturated KOH
and 12 M HCl solutions. All solutions were prepared with double-distilled water. All other chemicals were of
analytical grade and were used without additional purification.
3.2. Apparatus
All voltammetry and chronoamperometry experiments were conducted using an AUTOLAB PGSTAT 30 electrochemical analysis system operated under the GPES 4.7 software package (Eco Chemie, the Netherlands). EIS experiments were performed using an EG&G Princeton Applied Research Model 263A Potentiostat/Galvanostat.
A conventional three-electrode system comprising an MWCNTPE as working electrode, a saturated calomel
electrode (SCE) as reference electrode, and a platinum wire as auxiliary electrode was used at room temperature.
All potentials given in this paper were against the SCE. Measurements of pH were performed using a pH-meter
(Metrohm-654) and scanning electron microscopy (SEM) images were recorded with a MIRA3 TESCAN field
emission microscope.
3.3. Preparation of MWCNTPE and CPE
The MWCNTPE was prepared by thoroughly mixing 4.25 g of graphite powder and 0.75 g of MWCNTs with
1.8 mL of paraﬃn oil with a mortar and pestle. For preparing the CPE, 5 g of graphite powder was mixed with
1.8 mL of paraﬃn oil with a mortar and pestle.
The carbon pastes obtained from each of the above methods were packed into the hole of the electrode
body. The surfaces of the electrodes were cleaned by sequential mechanical polishing with 800, 2000, 2500, and
3000 grit polishing papers and were then smoothed with a clean paper until shiny surfaces were obtained.
3.4. Real sample preparation
3.4.1. Deferasirox tablet sample
First, one deferasirox tablet was weighed carefully. Then five deferasirox tablets were powdered and aliquots
equal to the weight of one tablet were weighed and transferred to a flask containing specified volumes of distilled
water and were agitated for 5 min. The sample solutions were centrifuged for 15 min and were finally filtered
through a filter paper (Whatman No. 42).
3.4.2. Spiked urine sample
For the preparation of a spiked urine solution, an aliquot amount of deferasirox was added to a specified volume
of urine sample and was dissolved completely.
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